150 Participants Needed

Strategy Training for Mild Cognitive Impairment

(ForAging Trial)

JW
JR
Overseen ByJuleen Rodakowski, OTD, MS, OTR/L
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Loss of cognitive abilities leading to Alzheimer's disease is progressive and destructive, leaving older adults disabled and unable to recall their past. The number of older adults with Alzheimer's disease is expected to triple by the year 2050, yet little research examines amyloid beta deposition, executive function, and progression of disability. This study will test the influence of a novel and promising non-pharmacological intervention, Strategy Training, on the progression of disability in a sample of 150 older adults with Mild Cognitive Impairment who have the option to complete a Positron Emission Tomography (PET) Imaging with Pittsburgh Compound B (PiB).

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.

Is strategy training safe for humans?

The research does not mention any safety concerns or adverse effects related to strategy training for mild cognitive impairment, suggesting it is generally safe for humans.12345

How does the treatment Strategy Training differ from other treatments for mild cognitive impairment?

Strategy Training, also known as Metacognitive Strategy Training, is unique because it focuses on teaching patients to use specific strategies and metacognitive skills (thinking about one's own thinking) to improve decision-making and executive functions, which are crucial for daily activities. Unlike other treatments, it emphasizes analytical thinking and compensatory techniques to enhance memory and attention, showing improvements that can be maintained over time.12467

What data supports the effectiveness of the treatment Strategy Training, Metacognitive Strategy Training for Mild Cognitive Impairment?

Research shows that strategy training can improve memory and executive functions (skills for managing tasks) in older adults with mild cognitive impairment. Studies found that participants who received strategy training had better memory recall and language skills, and reported fewer memory complaints in daily life.24678

Who Is on the Research Team?

JR

Juleen Rodakowski, OTD,MS,OTR/L

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for older adults living in the community who have been diagnosed with Mild Cognitive Impairment (MCI) and are noticing difficulties with daily activities. It's not suitable for those with other central nervous system disorders, substance disorders within the last five years, severe psychiatric conditions like bipolar disorder or schizophrenia, untreated major depression, severe medical conditions limiting daily activity, or if pregnant.

Inclusion Criteria

You live in your own home or apartment.
I have been diagnosed with Mild Cognitive Impairment.
I struggle with a daily activity.

Exclusion Criteria

You have had problems with drugs or alcohol in the last 5 years.
I have a brain disorder other than mild cognitive impairment.
You are currently pregnant.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Initial assessments including amyloid-beta deposition and neurocognitive function

1 week
1 visit (in-person)

Strategy Training

Participants engage in 10 sessions over 5 weeks with a trained research interventionist to identify and prioritize activity-based goals

5 weeks
10 visits (in-person)

Short-term Follow-up

Assessment of change in disability and cognitive function at 8 weeks post-intervention

8 weeks
1 visit (in-person)

Long-term Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 6 and 12 months post-intervention

12 months
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Strategy Training
Trial Overview The study is testing a non-drug intervention called Strategy Training against Enhanced Usual Care to see if it can slow down disability progression in people with MCI. Participants may also undergo PET Imaging using Pittsburgh Compound B to examine brain changes.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Strategy TrainingExperimental Treatment1 Intervention
Group II: Enhanced Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Published Research Related to This Trial

A novel cognitive training program called multi-strategic metamemory training significantly improved long-term delayed free recall and fluency in 66 older adults with mild cognitive impairment compared to a control group of 47 participants.
Participants in the training group also reported a significant decrease in subjective memory complaints, indicating that the program not only enhanced cognitive performance but also improved their perception of everyday memory function.
Cognitive Improvement in Older Adults with Mild Cognitive Impairment: Evidence from a Multi-Strategic Metamemory Training.Youn, JH., Park, S., Lee, JY., et al.[2020]
The process-based multi-task adaptive cognitive training (P-bM-tACT) program significantly improved executive function and other cognitive domains in older adults with mild cognitive impairment (MCI) over a 10-week period, with effects maintained for 3 months after training.
The program was well-received, demonstrating a high adherence rate of 83.4%, indicating its acceptability as a viable intervention for enhancing cognitive function in the community.
Transferability and sustainability of process-based multi-task adaptive cognitive training in community-dwelling older adults with mild cognitive impairment: a randomized controlled trial.Zhao, X., Ji, C., Zhang, C., et al.[2023]

Citations

Knowledge and use of memory strategies in amnestic mild cognitive impairment. [2018]
Strategy-Based Cognitive Training for Improving Executive Functions in Older Adults: a Systematic Review. [2022]
Cognitive Improvement in Older Adults with Mild Cognitive Impairment: Evidence from a Multi-Strategic Metamemory Training. [2020]
Cognitive stimulation of executive functions in mild cognitive impairment: specific efficacy and impact in memory. [2022]
Transferability and sustainability of process-based multi-task adaptive cognitive training in community-dwelling older adults with mild cognitive impairment: a randomized controlled trial. [2023]
Metacognitive Strategy Training Improves Decision-Making Abilities in Amnestic Mild Cognitive Impairment. [2023]
Developing a Non-Pharmacological Intervention for Individuals With Mild Cognitive Impairment. [2022]
Effects of Process-Based Cognitive Training on Memory in the Healthy Elderly and Patients with Mild Cognitive Impairment: A Randomized Controlled Trial. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security